Natixis Advisors
NPSP

Natixis Advisors’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Natixis Advisors’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12,506
Closed -$413K – 1305
2014
Q2 		$413K Buy
12,506
+2,038
+19% +$58.9K 0.01% 1052
2014
Q1 		$313K Buy
10,468
+1,589
+18% +$54.8K ﹤0.01% 1071
2013
Q4 		$270K Sell
8,879
-153
-2% -$4.21K ﹤0.01% 1045
2013
Q3 		$287K Buy
+9,032
New +$207K 0.01% 988

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Natixis Advisors's NPSP Position: Q3 2014 in Review

Natixis Advisors sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2014, closing a stake of 12,506 shares — an estimated $413K sold.

Natixis Advisors first reported a position in NPSP in Q3 2013 and held it in 4 quarters. The position peaked at $413K in Q2 2014. 200 funds tracked by Wall St. Rank hold NPSP as of Q3 2014.

  • Natixis Advisors reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Natixis Advisors sold 12,506 NPS PHARMACEUTICALS INC shares in Q3 2014, an estimated $413K.
  • Natixis Advisors first reported a position in NPS PHARMACEUTICALS INC in Q3 2013 and held it in 4 quarters.
  • Natixis Advisors's NPS PHARMACEUTICALS INC position peaked at $413K in Q2 2014.
  • 200 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2014.

Based on Natixis Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.